Mannkind reported $994K in Gross Profit on Sales for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Adma Biologics ADMA:US $ 3.66M 3.28M
Biocryst Pharmaceuticals BCRX:US $ 49.68M 2.95M
ChemoCentryx CCXI:US 5.25M 3.24M
Eli Lilly And LLY:US $ 5737.9M 211.8M
Halozyme Therapeutics HALO:US $ 101.36M 20.94M
Insmed INSM:US $ 40.92M 1.92M
JAZZ PHA JAZZ:US $ 698.44M 62.14M
Karyopharm Therapeutics KPTI:US $ 46.24M 79.28M
MacroGenics MGNX:US 11.05M 2.15M
Mannkind MNKD:US $ 0.99M 0.09M
Merk MRK:US $ 10567M 873M
Novo Nordisk A Fs NVO:US $ 35114M 3022M
Peregrine Pharmaceuticals PPHM:US $ 9.19M 2.2M
Pfizer PFE:US $ 15651M 1516M